How To Invest In Liquidia Technologies Inc Stock - LQDA Share Price Today & News | Stash
Invest in Liquidia Technologies Inc on Stash
Liquidia Technologies, Inc. is a clinical biopharmaceutical company, which is focused on developing and commercializing human therapeutics using its PRINT technology.
To buy fractional shares of Liquidia Technologies Inc stock, you'll need to sign up for Stash and open a personal portfolio.
Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.
Ticker: LQDA
Liquidia Technologies Inc
$79.94
-1.85%
(1W)
Disclosure
The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance over the last 5 years, for example, is simply what the average return per year (compound annual growth rate) was for the investment over the past 5 years.
Historical performance data are provided “as is” and solely for information purposes, is not advice or for trading purposes, does not reflect an investment strategy, may be subject to pricing delays, should not be used for tax reporting, may not reflect actual performance, and are gross of Stash fees. Market data provided by LSEG Data & Analytics in partnership with: LSEG FX in collaboration with: LSEG Risk Intelligence. Stash cannot and does not represent or guarantee that any of the information available via LSEG Data & Analytics is accurate, reliable, current, complete or appropriate for your needs. This material does not contain sufficient information to support an investment decision and it should not be relied upon by you in evaluating the merits of investing in any securities or products. In addition, users should make an independent assessment of the legal, regulatory, tax, credit and accounting implications and determine performance and yield are not a reliable indicator of current and future results.
LQDA Performance Breakdown
Share Price
The last publicly stated price for one share of an investment, updated every approximately 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).
$79.94
Today's change
This is how much an investment's price has changed over the last day of active trading. For example, if an investment's price was $10 yesterday, and today it rose to $11, you'd see a 1 day change of 10%.
6.2%
Year to date change (YTD)
This is the performance of the investments since the start of the year, updated approximately every 20 minutes during market hours (usually business days between 9:30 a.m. and 4:00 p.m. ET).
154.59%
Dividend yield
Some investments pay you profits or interest as you hold them. These payments are called dividends, and this value represents the dollar value as a percentage of the investment's share price.
0.0
Last dividend paid
The dollar value per share that was paid out to shareholders.
N/A
Last dividend pay date
The date shareholders were paid out for the last dividend issued.
N/A
About LQDA
Liquidia Technologies, Inc. is a clinical biopharmaceutical company, which is focused on developing and commercializing human therapeutics using its PRINT technology. PRINT technology is a particle engineering platform that enables precise production of uniform drug particles designed to improve the safety, efficacy, and performance of a wide range of therapies. The Company is engaged in developing product candidates from its pipeline, LIQ861 for the treatment of pulmonary arterial hypertension (PAH) and LIQ865 for the treatment of local post-operative pain. LIQ861 is an inhaled dry powder formulation of treprostinil designed to improve the therapeutic profile of treprostinil by enhancing deep-lung delivery and achieving higher dose levels than current inhaled therapies. LIQ865 has completed a Phase Ib clinical trial, designed to deliver sustained-release particles of bupivacaine, a non-opioid anesthetic and to treat local post-operative pain.